Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Step by step method to create a custom form in Drupal 8
In Drupal 8 form API is similar to the Drupal 7 Form API. forms still use array structure to render the data. but having separate validation and submission form.
|
Drupal 8: Creating custom contact us block with form field
Before we jump into the custom block writing. I would like to go through the blocker, which came to my learning. Hope it would be clear and simplest way to explain.
|
Drupal 8: How to create a custom block programatically
In Drupal 8 Blocks are made up of two separate API. Block Plugin API, is a reusable API and Block Entity API, use for block placement and visibility control.
|
Views Contextual Filters to Display Content by passing Raw value from URL in Drupal 8
Contextual Filters intelligently filters content to reduce the result set in various ways and is pretty powerful.It makes your View scalable and one View can be used on many pages on your site rather…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
